202-737-6770 (phone)
202-737-6776 (fax)
Washington, D.C. Office

Related Practices

Education

George Mason University, J.D., with distinction, 1990

Texas A&M University, Ph.D. in Biology, 1985

University of Connecticut, M.S. in Zoology, 1978

University of Connecticut, B.S. in Pre-Veterinary Technology, 1976

Jeremy M. Jay

Member

Dr. Jay practices law exclusively in the field of intellectual property. He is active in U.S. and foreign patent prosecution, and foreign patent oppositions, with particular emphasis in the areas of biotechnology, biomedicine, chemistry, and the mechanical arts. Recent technologies with which he has been involved include cloning and amplification techniques, recombinant antibodies, nucleic acid sequences, proteins, disease detection assays, medical treatments, blood filters, and polymeric membranes. He is also active in U.S. design patent prosecution.

Dr. Jay has extensive experience in managing patent portfolios, counseling, and rendering opinions for U.S. and foreign clients on inventorship, patent validity and infringement issues in a variety of technical fields. He has considerable experience in patent oppositions in Europe.

Dr. Jay has mechanical expertise in addition to his considerable biotechnical experience. He is a former automobile mechanic, and was certified by the National Institute of Automotive Service Excellence in various categories of automobile repair.

Prior to joining the firm, Dr. Jay was a judicial clerk for the Honorable Robert J. Yock of the United States Claims Court (now the U.S. Court of Federal Claims). Prior to the clerkship, he spent five years as a Patent Examiner in the area of biotechnology for the U.S. Patent and Trademark Office.

Professional Affiliations

American Intellectual Property Law Association (AIPLA)
Intellectual Property Owners Association (IPO)

Articles and Publications

“U.S. Design Patents,” Patent Times, No. 8:27-33 (2003)

Representative Matters

Dr. Jay has represented clients in numerous patent oppositions in Europe and other countries. Representative patent oppositions are identified below:

European Patent 1 163 045 (pertaining to positively charged membranes)
European Patent 1 053 033 (pertaining to blood products and filtration)
European Patent 0 749 345 (pertaining to leukocyte filters and venting systems)
European Patent 0 666 083 (pertaining to blood processing and filter systems)
European Patent 0 620 017 (pertaining to leukocyte filters for red blood cells)
European Patent 0 556 303 (pertaining to leukocyte filters and filter systems)
European Patent 0 856 319 (pertaining to leukocyte filters for platelets)
European Patent 0 484 517 (pertaining to leukocyte filters and venting systems)
European Patent 0 397 403 (pertaining to leukocyte filters for red blood cells)
European Patent 0 329 303 (pertaining to leukocyte filters for blood components)
European Patent 0 313 348 (pertaining to leukocyte filters and blood processing)
Japanese Patent 6042906 (pertaining to leukocyte filters for platelets)
Japanese Patent 3463297 (pertaining to leukocyte filters and venting systems)
Japanese Patent 3060985 (pertaining to filtration membranes)
Japanese Patent 2555722 (pertaining to leukocyte filters for red blood cells)

Speaking Engagements and Presentations

Dr. Jay has spoken at numerous seminars arranged by clients, especially, in view of his experience as a patent examiner, on patent procedures and practical patent strategies. He has also given various presentations to clients on other patent related issues, particularly with respect to the client’s worldwide business strategy.

Bar Admissions and Registrations

District of Columbia, 1991
Virginia, 1990
Registered to practice before the U.S. Patent and Trademark Office, 1989

Courts

U.S. Supreme Court
U.S. Court of Appeals for the Federal Circuit
U.S. Court of Appeals for the Fourth Circuit
U.S. Court of Appeals for the District of Columbia
D.C. Court of Appeals
U.S. District Court for the Eastern District of Virginia, Alexandria Division